Ipca Laboratories Limited, a active public limited company, was established on 19 October 1949 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1949PLC007837. Registered under ROC Roc Mumbai. it is listed on BSE: 524494 and NSE: IPCALAB. It has an authorized capital of ₹57.60 Cr and a paid-up capital of ₹25.37 Cr.
Formerly known as The Indian Pharmaceutical Combine Association Ltd. It upholds a compliant status. In 2024, it reported revenue of ₹6,277.75 Cr and a net worth of ₹6,348.71 Cr. Employing 17,422 professional, Its leadership includes Vivek Keshav Shiralkar (Director), Pranay Premchand Godha (Managing Director), Prashant Premchand Godha (Director). Past directors included Vishnu Atmaram Gore, Vivek Keshav Shiralkar, Ramappa Siddharamappa Hugar. It holds ₹2,708.14 Cr open charges and ₹2,002.16 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at 48 Kandivli Industrialestate Kandivali (W), Mumbai, Maharashtra, 400067.
L24239MH1949PLC007837
007837
19 October 1949
₹57.60 Cr
₹25.37 Cr
Roc Mumbai
Listed (BSE: 524494, NSE: IPCALAB)
Active
Explore comprehensive insights into Ipca Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Keshav Shiralkar | Director | 29 May 2024 | Current |
| Pranay Premchand Godha | Managing Director | 30 Jul 2009 | Current |
| Prashant Premchand Godha | Director | 28 Jul 2011 | Current |
| Narendra Mairpady | Director | 20 Oct 2022 | Current |
| Premchand Gigalal Godha | Whole-Time Director | 31 Jan 2012 | Current |
| Swati Arvind Patankar | Director | 14 Feb 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Dec 2009 | Past |
| Pramod Abcsdd | Additional Director | 12 Aug 2024 | Past |
| Pramod Abcsdd | Director | 30 Jan 2013 | Past |
| Pramod Abcsdd | Additional Director | 11 Nov 2008 | Past |
| Pramod Abcsdd | Director | 01 Apr 2019 | Past |
| Pramod Abcsdd | Director | 20 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ipca Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.94% increase. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth moved up by a moderate rise of 8.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Ipca Laboratories had a promoter holding of 46.30% and a public holding of 53.70%. The company had 3 Subsidiaries, 2 Joint Ventures and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹27,081,433,619.00
₹20,021,565,491.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2025 | Citi Bank N.A. | ₹166.60 Cr | Open |
| 29 Aug 2023 | Hdfc Bank Limited | ₹300.00 Cr | Open |
| 08 Aug 2023 | The Hongkong And Shanghai Banking Corporation Limited | ₹123.71 Cr | Open |
| 07 Oct 2022 | Hdfc Bank Limited | ₹391.22 Cr | Open |
| 02 Aug 2022 | Jp Morgan Chase Bank, N.A. | ₹114.21 Cr | Open |
Explore comprehensive loan charge details -
Ipca Laboratories has a workforce of 17422 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Ipca Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipca Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ipca Laboratories Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was completed.
Progress on Ipca Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
The activity A charge with Citi Bank N.A. amounted to Rs. 166.60 Cr with Charge ID 101041701 was registered on 24 Jan 2025. was completed.
Progress on Vivek Keshav Shiralkar was appointed as a Director was appointed as a Director on 29 May 2024 & has been associated with this company since 1 year 7 months . was documented.
Swati Arvind Patankar was appointed as a Director was appointed as a Director on 14 Feb 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 300.00 Cr with Charge ID 100775715 was registered on 29 Aug 2023. was documented.
The CIN of Ipca Laboratories Limited is L24239MH1949PLC007837.
Ipca Laboratories Limited is headquartered at 48 Kandivli Industrialestate Kandivali (W), Mumbai, Maharashtra, 400067.
Ipca Laboratories Limited was incorporated on 19 October 1949.
The current directors of Ipca Laboratories Limited are
The primary industry of Ipca Laboratories Limited is Manufacturing.
Ipca Laboratories Limited is listed. It is listed on BSE: 524494 and NSE: IPCALAB.
The authorized capital of Ipca Laboratories Limited is ₹57.60 Cr, and the paid-up capital is ₹25.37 Cr.
The compliance status of Ipca Laboratories Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX